Thromboembolism and Major Bleeding in Patients with Atrial Fibrillation and EHRA Type 2 Valvular Heart Disease: The Jordan Atrial Fibrillation (JoFib) Study

AIM: The risks of thromboembolism and major bleeding in atrial fibrillation (AF) patients were assessed according to the “Evaluated Heartvalves, Rheumatic or Artificial” (EHRA) classification. Additionally, the safety and efficacy of vitamin K antagonists (VKAs) and non-VKA oral anticoagulants (NOAC...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Najar, Mahasen, Al-Nusair, Mohammed, Alrabadi, Nasr, Alawaisheh, Ibrahim, Alawaisheh, Tuqa, Jarrah, Mohamad, Alzoubi, Karem H, Njem, Sumaya, Hamoudeh, Ayman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032139/
https://www.ncbi.nlm.nih.gov/pubmed/36968249
http://dx.doi.org/10.2147/VHRM.S387477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032139/
https://www.ncbi.nlm.nih.gov/pubmed/36968249
http://dx.doi.org/10.2147/VHRM.S387477

Ejemplares similares